A Phase 4 interventional study of Bupivacain and Magnesium sulfate in Postoperative Analgesia, sponsored by Cukurova University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-09-19.
Sponsored by Cukurova University · Phase 4, Interventional, and Treatment
In this study, it will aimed to evaluate the effect of magnesium sulfate and ketamine HCl added to local anesthetic on postoperative pain management in the ultrasound-guided erector spina plane (ESP) block in patients will undergo video-assisted thoracoscopic surgery.
Patients who will undergo lung resection with elective video-assisted thoracoscopic surgery will be included in the study. After routine monitoring, general anesthesia induction, and intubation with a double-lumen tube, patients who are placed in a lateral position will receive an ESP block at the T5 level, accompanied by ultrasonography, for postoperative analgesia.
For this purpose; Group I (control group) 0.5% bupivacaine 20 ml, Group II 0.5% bupivacaine 20 ml+150 mg MgSO4, Group III 0% ,5 bupivacaine 20 ml+2 mg/kg ketamine HCl will be administered. In all groups, the total volume will completed to 25 ml with 0.9% NaCl.
After surgery, hemodynamic values (heart rate, systolic and diastolic blood pressure), oxygen saturation, VAS scores (at rest and effort), Ramsey sedation score, patients satisfaction scores, PCA morphine consumption, additional analgesic requirements, and side effects will be recorded.
1,269 studies on the registry are indexed under Agnosia; 524 are open to participants now.
This study's enrollment of 60 is below the median of 75 across 1,089 interventional studies indexed under Agnosia.
Browse Agnosia studies →Cukurova University is the lead sponsor of 257 studies on the registry; 49 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Erector spinae plane block with 20 mL 0.5% bupivacaine
Drug: Bupivacain
Erector spinae plane block with 20 mL 0.5% bupivacaine+150 mg magnesium sulphate
Drug: Bupivacain · Drug: Magnesium sulfate
Erector spinae plane block with 20 mL 0.5% bupivacaine+2 mg/kg ketamine
Drug: Bupivacain · Drug: Ketamine Hydrochloride
Bupivacaine is a local anesthetic agent commonly used in ESP block.
Magnesium is an adjuvant agent that can be added to the local anesthetic agent to increase analgesic effectiveness..
Ketamine Hydrochloride is an also adjuvant agent that can be added to the local anesthetic to increase analgesic effectiveness.
pain scores
postoperative pain scores will recorded used Visual Analog Scale (VAS, 0= no pain, 10=worst pain)
Time frame: Change from baseline pain scores at 24 hours
morphine consumption
At the end of the surgery, patients will allowed to use the patient controlled analgesia (PCA) device. The PCA will deliver bolus doses of morphine (0,02 mg/kg) every 10 minutes without a background infusion.
Time frame: Change from baseline morphine consumption at 24 hours
side effects
All of patients will visited in the thoracic surgery ward after surgery and side effects (if occured) will recorded.
Time frame: postoperative 24 hours
This study is completed, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Magnesium Sulfate · Ketamine